Flagship platform · Genomics

Peptide medicine, matched to the genome.

U4U is Florida Man Bioscience’s genome-aware platform for peptide medicine — turning genetic context into a clearer options set for people and the licensed clinicians who care for them.

Genome-aware optionsPersonal, not genericA loop that learns

Status: Flagship platform story live on apex; PeptOdyssey is the shipping product surface.

Detect. Design. Deliver. Software first.

U4U is Florida Man Bioscience’s genome-aware platform for peptide medicine: Detect is the software wedge (PeptidIQ + PeptOdyssey). Design and Deliver are later legs — labeled as such.

What’s inside

PeptidIQ predicts. PeptOdyssey reports. The Tracker learns.

Luxury-clinic calm. Fast to load. Two to three colors on purpose — so the message, not the chrome, does the work.

Genome context

What your file can say

Variants mapped onto pathways and receptors that matter for peptide and hormone response — plain language first.

Options set

What to consider next

A structured dossier style surface: priorities, cautions, and open questions a clinician can act on.

Safety posture

Flags before hype

Contraindication-minded framing and honest confidence language — no miracle claims on a marketing page.

Follow-up

How the story continues

Room to fuse genetic priors with measured biomarkers so each check-in can tighten the picture.

Privacy lane

Trust models that fit

Cloud product surfaces when you choose them — and a local-first toolkit when you want files to stay put.

Research path

Built to mature

Software ships first. Delivery science and discovery programs sit alongside — labeled as research when they are.

Designed for you

Built to evolve with how care actually happens.

For people

Understand your starting point.

  • Bring a genome file you already have (or plan to obtain).
  • See peptide-relevant context without wading through raw VCF noise.
  • Leave with something you can take to a licensed clinician — not a self-prescription.

For clinicians & partners

A dossier, not a black box.

  • Structured outputs meant to be reviewed, not rubber-stamped by software.
  • Clear non-goals: not a diagnostic device, not autonomous prescribing.
  • A path into longitudinal tracking and the broader FMB platform.

The loop

Detect → Design → Deliver

01

Detect

PeptidIQ + PeptOdyssey: genome-aware decision support a licensed clinician can read — not a one-size protocol.

02

Design

Structure-guided visualization for peptide and protein work. Stage A software — not a wet-lab or therapeutic claim.

03

Deliver

MSP / vector nanodisk research on a longer horizon. Optionality — not a marketed therapeutic.

Why it matters

Marketing that stays honest.

Genome-aware options

Turn raw genetics into a clearer picture of peptide-relevant biology — structured for a licensed clinician to read.

Personal, not generic

Built around your file and your context, not a one-size handout. The goal is a decision-ready options set.

A loop that learns

Pair the first read with follow-up signals over time so the picture can refine as real-world data arrives.

  • Premium, fast-loading product marketing — message over chrome
  • Live path into PeptOdyssey analysis and tracking
  • Privacy toolkit lane when files should stay local

Quick answers

Straight talk.

Is U4U a medical device?
No. U4U is research and decision-support software from Florida Man Bioscience. It does not diagnose, treat, cure, or prevent disease.
How is this different from PeptOdyssey?
U4U is the internal platform name. PeptidIQ is the prediction engine. PeptOdyssey is the live dossier and tracking surface — including the iOS research path.
What about privacy?
We offer different trust models: product surfaces when you opt in, and u4u-privacy for local-first work on hardware you control.
Can I start today?
Yes — open PeptOdyssey to run a genome analysis, or contact the team for partnership and clinical workflow conversations.

Ready when you are

Take the next step with U4U.

Start a PeptOdyssey analysis, explore the privacy toolkit, or talk with the team about how genome-aware options fit your clinic or research workflow.